Dasotraline SEP360-105 Pediatric PK/PD Study

Clinical trial NCT02195167 · COMPLETED

Trial details

NCT number: NCT02195167
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Attention Deficit Hyperactivity Disorder

Start date: 2014-07-01
Primary completion: 2015-03-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.